Scarica l'app Stockscreener
58.71
6.62%
-4.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HIMS Giù?
Forum
Previsione
Precedente Chiudi:
$62.76
Aprire:
$62.12
Volume 24 ore:
29.34M
Relative Volume:
1.01
Capitalizzazione di mercato:
$12.76B
Reddito:
$1.78B
Utile/perdita netta:
$164.40M
Rapporto P/E:
85.09
EPS:
0.69
Flusso di cassa netto:
$236.51M
1 W Prestazione:
+0.61%
1M Prestazione:
+15.16%
6M Prestazione:
+117.46%
1 anno Prestazione:
+162.10%
Intervallo 1D:
$57.81
$63.63
Intervallo di 1 settimana:
$51.73
$65.30
Portata 52W:
$18.32
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Nome
Hims Hers Health Inc
Settore
Telefono
415-851-0195
Indirizzo
2269 CHESTNUT ST, SAN FRANCISCO
Confronta HIMS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
58.62 | 12.21B | 1.78B | 164.40M | 236.51M | 0.69 |
|
ZTS
Zoetis Inc
|
143.79 | 63.58B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.92 | 43.58B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.205 | 40.83B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.77 | 23.07B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
430.10 | 19.61B | 3.08B | 1.24B | 1.07B | 25.61 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-23 | Downgrade | Needham | Buy → Hold |
| 2025-06-04 | Reiterato | Needham | Buy |
| 2025-04-29 | Downgrade | TD Cowen | Buy → Hold |
| 2025-02-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Downgrade | Citigroup | Neutral → Sell |
| 2025-01-07 | Iniziato | BTIG Research | Buy |
| 2024-12-17 | Iniziato | Morgan Stanley | Overweight |
| 2024-11-14 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-08-22 | Iniziato | Needham | Buy |
| 2024-08-09 | Downgrade | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-04-16 | Downgrade | Jefferies | Buy → Hold |
| 2024-04-10 | Iniziato | Canaccord Genuity | Buy |
| 2024-02-28 | Aggiornamento | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2023-12-07 | Iniziato | Imperial Capital | In-line |
| 2023-07-28 | Iniziato | TD Cowen | Outperform |
| 2023-04-11 | Iniziato | Robert W. Baird | Neutral |
| 2023-02-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-11-08 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-08 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-07-15 | Iniziato | SVB Leerink | Underperform |
| 2022-04-14 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-10 | Iniziato | Deutsche Bank | Hold |
| 2021-12-02 | Iniziato | Jefferies | Hold |
| 2021-11-11 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Iniziato | BofA Securities | Neutral |
| 2021-05-20 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Iniziato | Truist | Hold |
| 2021-03-09 | Iniziato | Credit Suisse | Neutral |
| 2021-03-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Iniziato | Citigroup | Neutral |
| 2021-02-12 | Iniziato | Piper Sandler | Neutral |
| 2021-02-08 | Iniziato | Tigress Financial | Buy |
Mostra tutto
Hims Hers Health Inc Borsa (HIMS) Ultime notizie
Hims & Hers Stock Notches Best Day In 3 Months After BofA’s Bullish Call On Menopause Launch: Retail Hails Year’s ‘Best Swing Trade Stock’ - Stocktwits
Hims & Hers, Salesforce, Omeros, United Airlines, And Sea Ltd: Why These 5 Stocks Are On Investors' Radars Today - inkl
Why Hims & Hers Stock Blasted 16% Higher on Wednesday - The Globe and Mail
Hims & Hers stock climbs after menopause care launch - Rolling Out
Weight-loss drugs shook up the stock market. Menopause treatments could be next. - MarketWatch
Investors Are Buying Hims & Hers Health Stock Following Wednesday's Platform Expansion Announcement - Benzinga
Why Are Hims & Hers Health (HIMS) Shares Soaring Today - The Globe and Mail
Hims & Hers: Telehealth Triumph or Trouble? - StocksToTrade
FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly - MedShadow Foundation
Hims & Hers stock faces competition concerns despite positive BofA view - Investing.com
Hims & Hers offers menopause, perimenopause treatments - Seeking Alpha
Hims & Hers Health Brings Menopause, Perimenopause Treatments On Its Platform - Stocktwits
Hims & Hers launches perimenopause and menopause care on platform - Investing.com India
Hims & Hers stock rises after launching menopause treatment services By Investing.com - Investing.com Nigeria
Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026 - Hims Investor Relations
Hims & Hers to Offer Treatments for Menopause, Perimenopause - The Wall Street Journal
Hims & Hers stock rises after launching menopause treatment services - Investing.com
Not Your Mother's Menopause: Hers Sets a New Standard of Care for Women - Hims & Hers Newsroom
Promising Healthcare Stocks To ResearchOctober 14th - MarketBeat
Hims & Hers Gains 3.8% in 3 Months: Time to Hold the Stock or Sell? - TradingView
Should Investors Buy UnitedHealth Stock Instead of Hims & Hers Stock? - The Motley Fool
Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025 - Hims Investor Relations
Hims & Hers: Why I’m Betting On HIMS Heading To $100 (NYSE:HIMS) - Seeking Alpha
Best Healthcare Stocks To Keep An Eye OnOctober 12th - MarketBeat
Callan Family Office LLC Grows Stake in Hims & Hers Health, Inc. $HIMS - MarketBeat
Kingswood Wealth Advisors LLC Makes New $241,000 Investment in Hims & Hers Health, Inc. $HIMS - MarketBeat
Top Healthcare Stocks To Watch NowOctober 11th - MarketBeat
SLT Holdings LLC Purchases Shares of 8,125 Hims & Hers Health, Inc. $HIMS - MarketBeat
Total Wealth Planning & Management Inc. Makes New $593,000 Investment in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health, Inc. (HIMS) Dips More Than Broader Market: What You Should Know - sharewise.com
Why Hims & Hers Health (HIMS) Stock Is Nosediving - The Globe and Mail
Moderate Bearish Sentiment Surrounds HIMS as Options Activity Su - GuruFocus
Option traders moderately bearish in Hims and Hers Health with shares down 5.36% - TipRanks
Healthcare Stocks To Add to Your WatchlistOctober 10th - MarketBeat
HIMS: BofA Sees Revenue Challenges Ahead - GuruFocus
Hims and Hers stock price target maintained at $28 by BofA amid weak order trends - Investing.com
Promising Healthcare Stocks Worth WatchingOctober 9th - MarketBeat
How Hims & Hers founder Joe Spector turned 10 failures into $1B idea - Yahoo Finance
Hims & Hers Expands Personalized Care Access Via Telehealth Platform - Yahoo Finance
Hims & Hers survey: 94% of customers rate telehealth care equal to in-person - Investing.com Canada
Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor’s Office - Hims Investor Relations
Abel Hall LLC Purchases Shares of 4,993 Hims & Hers Health, Inc. $HIMS - MarketBeat
Robeco Institutional Asset Management B.V. Trims Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Is Hims & Hers Health Still Attractive After FDA Scrutiny Over Super Bowl Ad? - Yahoo Finance
Hims & Hers (HIMS) Jumps on Leadership Changes, Global Initiatives - MSN
Hims & Hers Looks To Close $10 ARPU Gap With Product Expansion And Partnerships - Seeking Alpha
Will Hims’ (HIMS) Leadership Shift Reveal New Strengths in Operational Execution? - Yahoo
10 Hot Stocks Sparking Buying Frenzy - Insider Monkey
Insider Selling: Hims & Hers Health (NYSE:HIMS) CFO Sells 11,595 Shares of Stock - MarketBeat
Hims & Hers Health (NYSE:HIMS) Trading 5.8% HigherHere's What Happened - MarketBeat
Hims & Hers CFO Okupe sells $669k in shares - Investing.com
Hims Hers Health Inc Azioni (HIMS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.28%
1.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):